APA

Tucker A. N., Tkaczuk K. A., Lewis L. M., Tomic D., Lim C. K. & Flaws J. A. (20050303). Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients. : Cancer letters.

Chicago

Tucker April N, Tkaczuk Katherine A, Lewis Lynn M, Tomic Dragana, Lim Chang K and Flaws Jodi A. 20050303. Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients. : Cancer letters.

Harvard

Tucker A. N., Tkaczuk K. A., Lewis L. M., Tomic D., Lim C. K. and Flaws J. A. (20050303). Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients. : Cancer letters.

MLA

Tucker April N, Tkaczuk Katherine A, Lewis Lynn M, Tomic Dragana, Lim Chang K and Flaws Jodi A. Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients. : Cancer letters. 20050303.